Hospital readmissions for patients with prostate cancer are higher after radiotherapy than after prostatectomy
| Autor: | Arshvin Kesavan, Keeran Vickneson, Kesavan Esuvaranathan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Investigative and Clinical Urology, Vol 63, Iss 1, Pp 34-41 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2466-0493 2466-054X |
| DOI: | 10.4111/icu.20210313 |
| Popis: | Purpose: To compare hospital readmissions, biochemical recurrence rates, incidence of metastasis, and cancer-specific and overall mortality for prostate cancer patients undergoing radiotherapy vs. radical prostatectomy. The secondary outcome was to identify patient and disease characteristics affecting physician’s choice of either therapy. Materials and Methods: A total of 297 patients diagnosed with prostate cancer between 2008 and 2014 were identified from a single academic center’s cancer database. Clinical information including age, ethnicity, comorbidities, prostate-specific antigen, Gleason score, stage, National Comprehensive Cancer Network (NCCN) risk group, biochemical recurrence, hospital readmissions, and survival outcomes were gathered and analyzed from ambulatory medical records until 2018. Results: Patients selected for radiotherapy were older and had more comorbidities and NCCN high-risk disease. Biochemical recurrence was higher after radical prostatectomy for locally advanced disease, 59.3% vs. 20.0% (p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|